Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Open Label Trial Evaluating The Safety, Tolerability And Immunogenicity Of 13-valent Pneumococcal Conjugate Vaccine In Healthy Children Aged 15 Months To 17 Years In Us.

NCT00761631 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00761631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00761631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Open Label Trial Evaluating The Safety, Tolerability And Immunogenicity Of 13-valent Pneumococcal Conjugate Vaccine In Healthy Children Aged 15 Months To 17 Years In Us.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
November 18, 2008
Completion date
August 10, 2010
Enrollment
1,200 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects